How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Overview of attention for article published in Cardiovascular Diabetology, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 32,782 followers.

Empagliflozin has been shown to reduce cardiovascular mortality........whilst increasing LDL 🤔 https://t.co/mivgMVFZNL

RT @drleonjimenez: How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical…

RT @drleonjimenez: How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical…

RT @drleonjimenez: How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.